{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T09:32:15Z","timestamp":1775208735181,"version":"3.50.1"},"reference-count":21,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T00:00:00Z","timestamp":1502409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP\u2010130316"],"award-info":[{"award-number":["MOP\u2010130316"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Academic Emergency Medicine"],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The objective of this study was to quantify the sensitivity of very low concentrations of high\u2010sensitivity cardiac troponin T (hsTnT) at <jats:styled-content style=\"fixed-case\">ED<\/jats:styled-content> arrival for acute myocardial infarction (<jats:styled-content style=\"fixed-case\">AMI<\/jats:styled-content>) in a large cohort of chest pain patients evaluated in real\u2010world clinical practice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective study included consecutive <jats:styled-content style=\"fixed-case\">ED<\/jats:styled-content> patients with suspected cardiac chest pain evaluated in four urban <jats:styled-content style=\"fixed-case\">ED<\/jats:styled-content>s, excluding those with <jats:styled-content style=\"fixed-case\">ST<\/jats:styled-content>\u2010elevation <jats:styled-content style=\"fixed-case\">AMI<\/jats:styled-content>, cardiac arrest or abnormal kidney function. The primary outcomes were <jats:styled-content style=\"fixed-case\">AMI<\/jats:styled-content> at 7, 30, and 90 days. Secondary outcomes included major adverse cardiac events (<jats:styled-content style=\"fixed-case\">MACE<\/jats:styled-content>; all\u2010cause mortality, <jats:styled-content style=\"fixed-case\">AMI<\/jats:styled-content>, and revascularization) and the individual <jats:styled-content style=\"fixed-case\">MACE<\/jats:styled-content> components. Test characteristics were calculated for hsTnT values from 3 to 200\u00a0ng\/L .<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 7,130 patients met inclusion criteria. <jats:styled-content style=\"fixed-case\">AMI<\/jats:styled-content> incidences at 7, 30, and 90 days were 5.8, 6.0, and 6.2%. When the hsTnT assay was performed at <jats:styled-content style=\"fixed-case\">ED<\/jats:styled-content> arrival, the limit of blank of the assay (3\u00a0ng\/L) ruled out 7\u2010day <jats:styled-content style=\"fixed-case\">AMI<\/jats:styled-content> in 15.5% of patients with 100% sensitivity and negative predictive value (<jats:styled-content style=\"fixed-case\">NPV<\/jats:styled-content>). The limit of detection of the assay (5\u00a0ng\/L) ruled out <jats:styled-content style=\"fixed-case\">AMI<\/jats:styled-content> in 33.6% of patients with 99.8% sensitivity and 99.95% <jats:styled-content style=\"fixed-case\">NPV<\/jats:styled-content> for 7\u2010day <jats:styled-content style=\"fixed-case\">AMI<\/jats:styled-content>. The limit of quantification (the Food and Drug Administration [<jats:styled-content style=\"fixed-case\">FDA<\/jats:styled-content>]\u2010approved cutoff for lower the reportable limit) of 6\u00a0ng\/L ruled out <jats:styled-content style=\"fixed-case\">AMI<\/jats:styled-content> in 42.2% of patients with 99.8% sensitivity and 99.95% <jats:styled-content style=\"fixed-case\">NPV<\/jats:styled-content>. The sensitivities of the cutoffs of &lt;3, &lt;5, and &lt;6\u00a0ng\/L for 7\u2010day <jats:styled-content style=\"fixed-case\">MACE<\/jats:styled-content> were 99.6, 97.4, and 96.6%, respectively. The <jats:styled-content style=\"fixed-case\">NPV<\/jats:styled-content>s of the cutoffs of &lt;3, &lt;5, and &lt;6\u00a0ng\/L for 7\u2010day <jats:styled-content style=\"fixed-case\">MACE<\/jats:styled-content> were 99.8, 99.5, and 99.4%, respectively. A secondary analysis was performed in a subgroup of 3,549 higher\u2010risk patients who underwent serial troponin testing. In this subgroup, a cutoff of 3\u00a0ng\/L ruled out 7\u2010day <jats:styled-content style=\"fixed-case\">AMI<\/jats:styled-content> in 9.6% of patients with 100% sensitivity and <jats:styled-content style=\"fixed-case\">NPV<\/jats:styled-content>, a cutoff of 5\u00a0ng\/L ruled out 7\u2010day <jats:styled-content style=\"fixed-case\">AMI<\/jats:styled-content> in 23.3% of patients with 99.7% sensitivity and 99.9% <jats:styled-content style=\"fixed-case\">NPV<\/jats:styled-content>, and a cutoff of 6\u00a0ng\/L ruled out 7\u2010day <jats:styled-content style=\"fixed-case\">AMI<\/jats:styled-content> in 29.8% of patients with 99.7 and 99.9% <jats:styled-content style=\"fixed-case\">NPV<\/jats:styled-content>. In the higher\u2010risk subgroup, the sensitivities of cutoffs of &lt;3, &lt;5, and &lt;6\u00a0ng\/L for 7\u2010day <jats:styled-content style=\"fixed-case\">MACE<\/jats:styled-content> were 99.8, 97.4, and 96.6%, respectively. In this higher\u2010risk subgroup, the <jats:styled-content style=\"fixed-case\">NPV<\/jats:styled-content> of cutoffs of &lt;3, &lt;5, and &lt;6\u00a0ng\/L for 7\u2010day <jats:styled-content style=\"fixed-case\">MACE<\/jats:styled-content> were 99.7, 98.5, and 98.4%, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>When used in real\u2010world clinical practice conditions, hsTnT concentrations\u00a0&lt;\u00a06\u00a0ng\/L (below the lower reportable limit for an <jats:styled-content style=\"fixed-case\">FDA<\/jats:styled-content>\u2010approved assay) at the time of <jats:styled-content style=\"fixed-case\">ED<\/jats:styled-content> arrival can rule out <jats:styled-content style=\"fixed-case\">AMI<\/jats:styled-content> with very high sensitivity and <jats:styled-content style=\"fixed-case\">NPV<\/jats:styled-content>. The sensitivity for <jats:styled-content style=\"fixed-case\">MACE<\/jats:styled-content> is unacceptably low, and thus a single\u2010troponin rule\u2010out strategy should only be used in the context of a structured risk evaluation.<\/jats:p><\/jats:sec>","DOI":"10.1111\/acem.13229","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T14:51:24Z","timestamp":1495551084000},"page":"1267-1277","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Undetectable Concentrations of a Food and Drug Administration\u2013approved High\u2010sensitivity Cardiac Troponin T Assay to Rule Out Acute Myocardial Infarction at Emergency Department Arrival"],"prefix":"10.1111","volume":"24","author":[{"given":"Andrew D.","family":"McRae","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine University of Calgary Calgary Alberta"},{"name":"Department of Community Health Sciences University of Calgary Calgary Alberta"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant","family":"Innes","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine University of Calgary Calgary Alberta"},{"name":"Department of Community Health Sciences University of Calgary Calgary Alberta"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Graham","sequence":"additional","affiliation":[{"name":"Department of Cardiology University of Alberta Edmonton Alberta"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eddy","family":"Lang","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine University of Calgary Calgary Alberta"},{"name":"Department of Community Health Sciences University of Calgary Calgary Alberta"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James E.","family":"Andruchow","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine University of Calgary Calgary Alberta"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunqi","family":"Ji","sequence":"additional","affiliation":[{"name":"Alberta Health Services Calgary Alberta"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shabnam","family":"Vatanpour","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine University of Calgary Calgary Alberta"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasnima","family":"Abedin","sequence":"additional","affiliation":[{"name":"Alberta Health Services Calgary Alberta"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Community Health Sciences University of Calgary Calgary Alberta"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle A.","family":"Southern","sequence":"additional","affiliation":[{"name":"Department of Community Health Sciences University of Calgary Calgary Alberta"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Wang","sequence":"additional","affiliation":[{"name":"Alberta Health Services Calgary Alberta"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isolde","family":"Seiden\u2010Long","sequence":"additional","affiliation":[{"name":"Calgary Laboratory Services Calgary Alberta"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"DeKoning","sequence":"additional","affiliation":[{"name":"Calgary Laboratory Services Calgary Alberta"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kavsak","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Medicine McMaster University Hamilton Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,8,11]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2003.027599"},{"issue":"43","key":"e_1_2_8_3_1","first-page":"1","article-title":"Emergency department visits for chest pain and abdominal pain: United States, 1999\u20132008","author":"Buhuiya FA","year":"2010","journal-title":"NCHS Data Brief"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2012.09.171"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1481803500005303"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.09.016"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h15"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2562"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv320"},{"key":"e_1_2_8_10_1","unstructured":"National Institute for Health and Care Excellence.Myocardial Infarction (acute): Early rule out using high\u2010sensitivity troponin tests (Elecsys Troponin T High\u2010Sensitive ARCHITECT STAT High Sensitive Troponin I and AccuTnI+3 assays)(DG15). 7: Recommendations for Further Research. 2014. Available at:https:\/\/www.nice.org.uk\/guidance\/dg15\/chapter\/7-Recommendations-for-further-researchAccessed Sep 20 2016."},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.2270"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2012.197434"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2016.255448"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.plabm.2015.02.001"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2016.265058"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2015.08.041"},{"key":"e_1_2_8_17_1","first-page":"1225","article-title":"Overview of the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease. On behalf of the APPROACH investigators","volume":"16","author":"Ghali WA","year":"2000","journal-title":"Can J Cardiol"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2015.07.006"},{"issue":"1","key":"e_1_2_8_19_1","first-page":"S17","article-title":"Construct and outcome validity of CTAS Chest Pain","volume":"14","author":"Bullard MJ","year":"2012","journal-title":"CJEM"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.114.001384"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/HPC.0000000000000059"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-200208000-00007"}],"container-title":["Academic Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Facem.13229","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/acem.13229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T17:51:36Z","timestamp":1696009896000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/acem.13229"}},"subtitle":[],"editor":[{"given":"Brian C.","family":"Hiestand","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,11]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.1111\/acem.13229"],"URL":"https:\/\/doi.org\/10.1111\/acem.13229","archive":["Portico"],"relation":{},"ISSN":["1069-6563","1553-2712"],"issn-type":[{"value":"1069-6563","type":"print"},{"value":"1553-2712","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,11]]},"assertion":[{"value":"2017-03-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-05-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-08-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}